25iP-NBOMe

25iP-NBOMe
Clinical data
ATC code
  • none
Identifiers
CAS Number
PubChem CID
ChemSpider
Chemical and physical data
Formula C21H29NO3
Molar mass 343.47 g·mol−1
3D model (JSmol)

25iP-NBOMe (2C-iP-NBOMe, NBOMe-2C-iP) is a derivative of the phenethylamine hallucinogen 2C-iP, which acts as a highly potent partial agonist for the human 5-HT2A receptor.[1]

Legality

United Kingdom

This substance is a Class A drug in the United Kingdom as a result of the N-benzylphenethylamine catch-all clause in the Misuse of Drugs Act 1971.[2]

References

  1. https://bitnest.netfirms.com/external.php?id=%257DbxUaPRU%2505%255CG%252B%2527%252AFQ%2502%2518%2508U%250ATv
  2. "The Misuse of Drugs Act 1971 (Ketamine etc.) (Amendment) Order 2014". www.legislation.gov.uk.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.